RIM
LAB icon

RS Investment Management’s Standard BioTools LAB Stock Holding History

RS Investment Management’s Portfolio LAB Stock Details LAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-909,448
Closed -$38.3M – 368
2015
Q1 		$38.3M Buy
909,448
+115,970
+15% +$4.58M 0.34% 107
2014
Q4 		$26.8M Buy
793,478
+256,730
+48% +$7.27M 0.24% 145
2014
Q3 		$13.2M Buy
536,748
+12,100
+2% +$340K 0.12% 214
2014
Q2 		$15.4M Buy
524,648
+215,548
+70% +$6.91M 0.13% 203
2014
Q1 		$13.6M Buy
309,100
+29,008
+10% +$1.28M 0.08% 213
2013
Q4 		$10.7M Buy
+280,092
New +$8.25M 0.07% 217

Other funds holding LAB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

RS Investment Management's LAB Position: Q2 2015 in Review

RS Investment Management sold out of Standard BioTools (LAB) in Q2 2015, closing a stake of 909,448 shares — an estimated $38.3M sold.

RS Investment Management first reported a position in LAB in Q4 2013 and held it in 6 quarters. The position peaked at $38.3M in Q1 2015. 107 funds tracked by Wall St. Rank hold LAB as of Q2 2015.

  • RS Investment Management reported no remaining Standard BioTools position as of Q2 2015 after selling out during the quarter.
  • RS Investment Management sold 909,448 Standard BioTools shares in Q2 2015, an estimated $38.3M.
  • RS Investment Management first reported a position in Standard BioTools in Q4 2013 and held it in 6 quarters.
  • RS Investment Management's Standard BioTools position peaked at $38.3M in Q1 2015.
  • 107 funds tracked by Wall St. Rank held Standard BioTools as of Q2 2015.

Based on RS Investment Management's 13F filing for Q2 2015, filed 13 Aug 2015.